Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

$22.49

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Common-Size Balance Sheet: Assets

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Abiomed Inc., common-size consolidated balance sheet: assets

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Cash and cash equivalents
Short-term marketable securities
Accounts receivable, net
Inventories, net
Prepaid expenses and other current assets
Current assets
Long-term marketable securities
Property and equipment, net
Goodwill
Other intangibles, net
Deferred tax assets
Investment in Shockwave Medical
Other investments
Operating lease right-of-use assets
Cross-currency swap
Other intangible assets and other assets
Other assets
Long-term assets
Total assets

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Abiomed Inc. current assets as a percentage of total assets increased from 2020 to 2021 and from 2021 to 2022.
Property and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Abiomed Inc. property and equipment, net as a percentage of total assets decreased from 2020 to 2021 and from 2021 to 2022.
Long-term assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Abiomed Inc. long-term assets as a percentage of total assets decreased from 2020 to 2021 and from 2021 to 2022.